Vanguard Group’s Biofrontera BFRI Stock Holding History

Vanguard Group’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$65K	Hold	113,951	–	–	﹤0.01%	4216
2025 Q3	$112K	Buy	+113,951	New	+$103K	﹤0.01%	4213
2023 Q4	–	Sell	-10,954	Closed	-$96.1K	–	4500
2023 Q3	$96.1K	Buy	10,954 +1	+0%	+$10	﹤0.01%	4353
2023 Q2	$114K	Hold	10,953	–	–	﹤0.01%	4379
2023 Q1	$134K	Hold	10,953	–	–	﹤0.01%	4371
2022 Q4	$201K	Buy	10,953 +323	+3%	+$6.6K	﹤0.01%	4311
2022 Q3	$223K	Hold	10,630	–	–	﹤0.01%	4398
2022 Q2	$395K	Buy	10,630 +3,072	+41%	+$186K	﹤0.01%	4343
2022 Q1	$503K	Sell	7,558 -106	-1%	-$7.68K	﹤0.01%	4398
2021 Q4	$1.15M	Buy	+7,664	New	+$839K	﹤0.01%	4227

Other funds holding BFRI

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group's BFRI Position: Q4 2025 in Review

Vanguard Group held its Biofrontera (BFRI) position steady in Q4 2025 at 113,951 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #4216.

Vanguard Group first reported a position in BFRI in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.15M in Q4 2021. 14 funds tracked by Wall St. Rank hold BFRI as of Q4 2025.

Vanguard Group held 113,951 shares of Biofrontera worth $65K as of Q4 2025.
Vanguard Group left its Biofrontera share count unchanged in Q4 2025.
Biofrontera made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4216 holding.
Vanguard Group first reported a position in Biofrontera in Q4 2021 and has held it in 10 quarters since.
Vanguard Group's Biofrontera position peaked at $1.15M in Q4 2021.
14 funds tracked by Wall St. Rank held Biofrontera as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.